Prosecution Insights
Prosecution Insights
Tech Center 3700 • Art Units: 1614 1615 1616 3785
This examiner grants 54% of resolved cases
Jeffrey T. Palenik is an examiner in Art Unit 1614, located within Tech Center 3700. The examiner has resolved 885 cases, maintaining an allowance rate of 53.6 percent. This rate suggests a more challenging prosecution environment where just over half of the applications are granted. The median days to allowance is 1237, indicating a relatively long duration for the examination process. Practitioners should prepare for a rigorous and potentially lengthy prosecution when their cases are assigned to this examiner in Art Unit 1614.
The interview lift of 27.2 percent is a critical data point for strategy. Given the 53.6 percent allowance rate, an interview provides a significant boost to the probability of obtaining a patent. This 27.2 percent lift suggests that the examiner is responsive to the clarifications and arguments presented during oral discussions. With 885 resolved cases, the data is well-established. Applicants should consider the 1237-day median pendency as a baseline and use interviews as a primary tool to improve their odds of success beyond the standard allowance rate.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 19436348 | COMPOSITIONS COMPRISING AN ACTIVE INGREDIENT MIXTURE COMPRISING SILICON AND BIOTIN AND METHODS OF USE | Final Rejection | Nutrition21, LLC |
| 18841884 | COMPOSITIONS COMPRISING AN ACTIVE INGREDIENT MIXTURE COMPRISING SILICON AND BIOTIN AND METHODS OF USE | Non-Final OA | Nutrition21, LLC |
| 18484074 | HAIR CARE COMPOSITIONS COMPRISING MALODOR REDUCTION MATERIALS | Non-Final OA | The Procter & Gamble Company |
| 18767430 | ANTIMICROBIAL OR WOUND CARE MATERIALS, DEVICES AND USES | Final Rejection | Smith & Nephew PLC |
| 17997414 | THREE-DIMENSIONALLY PRINTABLE ANTIVIRAL FILAMENT | Non-Final OA | Stratasys, Inc, |
| 18849399 | METHODS OF PREPARING CARRIER-BASED DRY POWDERS FOR INHALATION | Non-Final OA | Board of Regents, The University of Texas System |
| 18717176 | AQUEOUS LIQUID COSMETIC | Final Rejection | MITSUBISHI PENCIL COMPANY, LIMITED |
| 18756678 | COACERVATE CLEANSING COMPOSITION WITH ACNE TREATMENT ACTIVE | Non-Final OA | L'OREAL |
| 18543597 | COMPOSITIONS CONTAINING BIS-ETHYLHEXYLOXYPHENOL METHOXYPHENYL TRIAZINE AND ACTIVE AGENT | Final Rejection | L'OREAL |
| 18549841 | PROCESS FOR REMOVING THE COLOUR FROM PREVIOUSLY COLOURED HAIR KERATIN FIBERS | Non-Final OA | L'Oreal |
| 18265749 | USE OF PARTICULAR AMINO ACIDS AS A PRETREATMENT FOR A PROCESS FOR DYEING OR BLEACHING KERATIN FIBRES | Non-Final OA | L'Oreal |
| 18723758 | BAR COMPOSITION HAVING ENHANCED ANTIMICROBIAL ACTIVITY | Non-Final OA | Conopco, Inc., d/b/a UNILEVER |
| 18718702 | IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS | Final Rejection | GIVAUDAN SA |
| 18501402 | Treating Alagille Syndrome (ALGS) | Non-Final OA | Albireo AB |
| 18222775 | NANOMEDICINES FOR TREATMENT OF DISEASE | Non-Final OA | Chapman University |
| 17997674 | REDUCTION OF CYTOKINE STORM AND PATHOLOGICAL INFLAMMATION INCLUDING CAUSED BY CORONAVIRUS USING SPHAGNUM AND EXTRACTS THEREOF | Final Rejection | FIGENE, LLC |
| 18260222 | Formulations of a Prophylactic Nasal Spray and Methods of Use and Manufacture Thereof | Final Rejection | NTBY Moss LLC |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy